Yingchun Xu Selected Research

Yingchun Xu Research Topics

Disease

29	Infections 12/2022 - 06/2010
25	Neoplasms (Cancer) 01/2022 - 01/2011
15	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2011
10	Intraabdominal Infections 01/2021 - 06/2010
9	COVID-19 01/2022 - 01/2020
6	Neoplasm Metastasis (Metastasis) 10/2021 - 10/2017
5	Urinary Tract Infections (Urinary Tract Infection) 01/2021 - 09/2018
5	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021 - 11/2011
5	Fever (Fevers) 05/2020 - 09/2015
4	Inflammation (Inflammations) 12/2021 - 11/2020
4	Pneumonia (Pneumonitis) 10/2020 - 10/2015
3	Abscess 08/2021 - 01/2019
3	Carcinoma (Carcinomatosis) 01/2021 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 04/2011
2	Melanoma (Melanoma, Malignant) 10/2021 - 03/2020
2	Liver Abscess 01/2021 - 01/2020
2	Rheumatic Diseases (Rheumatism) 01/2021 - 12/2016
2	Hemorrhage 01/2021 - 04/2020
2	Meningitis 01/2021 - 10/2016
2	Coinfection 04/2020 - 11/2018
2	Opportunistic Infections (Opportunistic Infection) 01/2020 - 10/2019
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020 - 12/2016
2	Encephalitis (Encephalitis, Rasmussen) 12/2019 - 01/2018
2	Febrile Seizures (Febrile Seizure) 12/2019 - 01/2018
2	Hepatitis B 11/2019 - 03/2016
2	Hepatocellular Carcinoma (Hepatoma) 11/2019 - 10/2016
2	Wounds and Injuries (Trauma) 12/2016 - 11/2016
2	Sepsis (Septicemia) 02/2016 - 12/2002
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 01/2011
2	Lung Neoplasms (Lung Cancer) 01/2016 - 04/2011
1	Pneumococcal Infections 01/2022
1	Lymphopenia (Lymphocytopenia) 02/2021

Drug/Important Bio-Agent (IBA)

17	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2010
10	Carbapenems (Carbapenem Antibiotics)IBA 12/2022 - 06/2012
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2016
8	Pharmaceutical PreparationsIBA 01/2021 - 11/2016
8	CytokinesIBA 11/2020 - 10/2015
6	Biomarkers (Surrogate Marker)IBA 12/2021 - 05/2014
5	Biological ProductsIBA 01/2022 - 11/2015
4	AntibodiesIBA 01/2022 - 06/2019
4	AntigensIBA 09/2021 - 02/2017
4	Imipenem FDA Link 08/2021 - 01/2017
4	Interleukin-6 (Interleukin 6)IBA 02/2021 - 10/2015
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 11/2018
4	RNA (Ribonucleic Acid)IBA 03/2020 - 03/2017
3	Indicators and Reagents (Reagents)IBA 12/2021 - 10/2002
3	Amikacin (A.M.K)FDA LinkGeneric 08/2021 - 06/2012
3	Anti-Infective Agents (Microbicides)IBA 01/2021 - 11/2011
3	Peptides (Polypeptides)IBA 01/2021 - 05/2014
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2011
3	beta-Lactamases (beta-Lactamase)IBA 01/2021 - 12/2002
3	Immunoglobulin G (IgG)IBA 12/2020 - 06/2019
3	Antiphospholipid AntibodiesIBA 12/2020 - 01/2020
3	Immunoconjugates (Immunoconjugate)IBA 11/2020 - 02/2017
3	Interleukin-8 (Interleukin 8)IBA 12/2019 - 10/2015
3	Hormones (Hormone)IBA 02/2019 - 10/2017
3	Progesterone Receptors (Progesterone Receptor)IBA 11/2018 - 03/2017
3	Estrogen ReceptorsIBA 11/2018 - 03/2017
2	Colistin (Coly-Mycin)FDA Link 12/2022 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2017
2	Penicillins (Penicillin)FDA Link 01/2022 - 01/2021
2	sortase AIBA 09/2021 - 02/2017
2	Ertapenem (Invanz)FDA Link 08/2021 - 01/2017
2	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 01/2017
2	relebactamIBA 01/2021 - 12/2020
2	Immunoglobulin A (IgA)IBA 12/2020 - 04/2020
2	Ceftaroline FDA Link 10/2020 - 11/2018
2	ceftazidime drug combination avibactamIBA 10/2020 - 11/2018
2	Interleukin-2 (IL2)IBA 04/2020 - 10/2015
2	ChemokinesIBA 03/2020 - 01/2018
2	LigandsIBA 01/2020 - 02/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 10/2019
2	Immune Checkpoint InhibitorsIBA 01/2020 - 10/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2019 - 01/2017
2	Interleukin-10 (Interleukin 10)IBA 12/2019 - 10/2015
2	Epidermal Growth Factor (EGF)IBA 01/2019 - 11/2018
2	TOR Serine-Threonine KinasesIBA 08/2018 - 11/2015
2	DNA (Deoxyribonucleic Acid)IBA 03/2017 - 03/2016
2	Messenger RNA (mRNA)IBA 03/2017 - 10/2016
2	SuspensionsIBA 01/2017 - 09/2011
2	SteroidsIBA 12/2016 - 10/2015
2	flomoxefIBA 05/2015 - 04/2015
1	Monoclonal AntibodiesIBA 01/2022
1	Contrast MediaIBA 01/2022
1	LactamsIBA 01/2022
1	Penicillin-Binding Proteins (Penicillin-Binding Protein)IBA 01/2022
1	Nucleic AcidsIBA 01/2022
1	ThrombomodulinIBA 12/2021
1	Syndecan-1 (Syndecan 1)IBA 12/2021
1	DNA VaccinesIBA 10/2021
1	Bispecific AntibodiesIBA 09/2021
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 08/2021
1	AlbuminsIBA 02/2021
1	fibrin fragment D (D-dimer)IBA 02/2021

Therapy/Procedure

19	Therapeutics 01/2022 - 01/2011
5	Immunotherapy 01/2022 - 01/2019
2	Precision Medicine 11/2020 - 03/2020
2	Length of Stay 05/2020 - 06/2010
2	Drug Therapy (Chemotherapy) 01/2020 - 11/2015
1	Glycemic Control 01/2021